3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Osteosarcoma
1
Neuroblastoma
1
Chickenpox
1
Interventions
Cyclophosphamide
10
Magnetic Resonance Spectroscopy
8
Temozolomide
6
Biopsy
6
dinutuximab
5
X-Rays
5
Topotecan
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Irinotecan
5
Etoposide
3
Colony-Stimulating Factors
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
sargramostim
2
pembrolizumab
2
palbociclib
2
naxitamab
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
fludarabine
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
Lenalidomide
2
Isotretinoin
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neuroblastoma
×
Herpes Zoster Vaccine
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled